1 | 2512929 | In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactone. | Biochem Pharmacol | 1989 Nov 15 |
3 |
2 | 3038751 | Influence of type and opsonization of ingested particle on intracellular free calcium distribution and superoxide production by human neutrophils. | Infect Immun | 1987 Aug |
1 |
3 | 3922423 | Effects of stilbenes on arachidonate metabolism in leukocytes. | Biochim Biophys Acta | 1985 Apr 25 |
2 |
4 | 7554275 | The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. | Clin Chim Acta | 1995 Mar 31 |
1 |
5 | 7664473 | Beyond alcohol: beverage consumption and cardiovascular mortality. | Clin Chim Acta | 1995 Jun 15 |
1 |
6 | 9391166 | Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. | Proc Natl Acad Sci U S A | 1997 Dec 9 |
3 |
7 | 9581680 | Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. | Hepatology | 1998 May |
3 |
8 | 9586953 | Interaction of transresveratrol with plasma lipoproteins. | Biochem Pharmacol | 1998 Mar 15 |
1 |
9 | 9605577 | Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. | Br J Pharmacol | 1998 Apr |
6 |
10 | 9680369 | Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. | Blood | 1998 Aug 1 |
6 |
11 | 9705326 | Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. | J Biol Chem | 1998 Aug 21 |
8 |
12 | 9785383 | Paradoxical effects of resveratrol on the two prostaglandin H synthases. | Prostaglandins Other Lipid Mediat | 1998 Jun |
6 |
13 | 9846848 | Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. | Am J Clin Nutr | 1998 Dec |
11 |
14 | 9865727 | Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. | Cancer Res | 1998 Dec 15 |
13 |
15 | 9886234 | Lectin-mediated drug targeting: quantification of binding and internalization of Wheat germ agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells. | J Drug Target | 1998 |
1 |
16 | 9974427 | Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells : A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. | Arterioscler Thromb Vasc Biol | 1999 Feb |
12 |
17 | 10069459 | Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. | Carcinogenesis | 1999 Feb |
8 |
18 | 10188978 | Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. | Br J Pharmacol | 1999 Feb |
5 |
19 | 10228948 | Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. | J Cell Physiol | 1999 Jun |
2 |
20 | 10232077 | Anti-allergic action of resveratrol and related hydroxystilbenes. | Planta Med | 1999 Apr |
2 |
21 | 10320034 | Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. | Neurosci Lett | 1999 Apr 2 |
12 |
22 | 10328958 | Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. | Exp Cell Res | 1999 May 25 |
5 |
23 | 10356984 | Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. | FEBS Lett | 1999 May 14 |
12 |
24 | 10363980 | Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. | Cancer Res | 1999 Jun 1 |
3 |
25 | 10370867 | Cancer chemopreventive activity of resveratrol. | Drugs Exp Clin Res | 1999 |
12 |
26 | 10370870 | Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant? | Drugs Exp Clin Res | 1999 |
3 |
27 | 10374244 | Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. | Phytomedicine | 1999 May |
4 |
28 | 10381133 | Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. | Cancer Lett | 1998 Dec 11 |
2 |
29 | 10402233 | Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. | Int J Oncol | 1999 Aug |
3 |
30 | 10403535 | Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. | Cancer Lett | 1999 Jun 1 |
1 |
31 | 10448061 | Resveratrol is a selective human cytochrome P450 1A1 inhibitor. | Biochem Biophys Res Commun | 1999 Aug 19 |
1 |
32 | 10491155 | Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. | Eur J Biochem | 1999 Oct 1 |
4 |
33 | 10492890 | Chemoprevention of cancer and cardiovascular disease by resveratrol. | Proc Natl Sci Counc Repub China B | 1999 Jul |
5 |
34 | 10496959 | Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. | Mol Pharmacol | 1999 Oct |
10 |
35 | 10496962 | Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. | Mol Pharmacol | 1999 Oct |
6 |
36 | 10498846 | trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. | Br J Pharmacol | 1999 Sep |
5 |
37 | 10563851 | PH-dependent forms of red wine anthocyanins as antioxidants. | J Agric Food Chem | 1999 Jan |
1 |
38 | 10600179 | The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity. | Arch Biochem Biophys | 1999 Dec 15 |
3 |
39 | 10606230 | Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. | Cancer Res | 1999 Dec 1 |
4 |
40 | 10668496 | Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. | Ann N Y Acad Sci | 1999 |
5 |
41 | 10698352 | Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. | Life Sci | 2000 Jan 21 |
1 |
42 | 10718345 | Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. | Biochem Pharmacol | 2000 Apr 1 |
3 |
43 | 10769659 | Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. | Anticancer Res | 2000 Jan-Feb |
6 |
44 | 10775377 | Separation of biologically active lipids from red wine. | J Agric Food Chem | 2000 Apr |
1 |
45 | 10783318 | Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. | Carcinogenesis | 2000 May |
2 |
46 | 10824865 | Inhibitory effect of resveratrol on free radical generation in blood platelets. | Acta Biochim Pol | 1999 |
2 |
47 | 10837497 | Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. | J Biol Chem | 2000 Jun 9 |
2 |
48 | 10843709 | Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. | J Immunol | 2000 Jun 15 |
11 |
49 | 10848832 | Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. | Br J Haematol | 2000 May |
14 |
50 | 10854714 | Ligand structure-dependent differences in activation of estrogen receptor alpha in human HepG2 liver and U2 osteogenic cancer cell lines. | Mol Cell Endocrinol | 2000 Apr 25 |
2 |